Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....